Dwarfism

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2007-03-26
EMA Application withdrawn: Iplex (mecasermin rinfabate) — Insmed Europe Ltd
The EMA application for Iplex (mecasermin rinfabate) by Insmed Europe Ltd has been withdrawn.